- Research works
- 6 ▲ 142% vs 2013–17
- Citations
- 154 25.8 per fractional work
- Top-10% rate
- 34.7% record average 16.5%
- Open access
- 71% world 28%
Not ranked overall: Celdara Medical (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Celdara Medical (United States) publish most on?
By volume in 2022–2025: Amyotrophic Lateral Sclerosis Research, Systemic Sclerosis and Related Diseases, CAR-T cell therapy research and Ferroptosis and cancer prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Amyotrophic Lateral Sclerosis Research Neurology 0 works
- 2 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
- 3 CAR-T cell therapy research Oncology 0 works
- 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
- 5 Cutaneous lymphoproliferative disorders research Dermatology 0 works
- 6 Virus-based gene therapy research Genetics 0 works
- 7 Immunotherapy and Immune Responses Immunology 0 works
- 8 Inflammatory Myopathies and Dermatomyositis Epidemiology 0 works
- 9 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
- 10 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Celdara Medical (United States)'s research output changed?
Output in 2018–2022 was 142% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lebanon
- Dartmouth–Hitchcock Medical Center
- Dartmouth Psychiatric Research Center
- Dartmouth Institute for Health Policy and Clinical Practice
- Children's Hospital at Dartmouth Hitchcock
- Adimab (United States)
- Simbex (United States)
- Woomera Therapeutics
- DoseOptics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.